Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Theranostic Value of STARD3 in Colorectal Cancer: The STAR Study: a Monocentric Observational Study

NCT06136949 is registered in ClinicalTrials.gov with Centro di Riferimento Oncologico - Aviano as lead sponsor.

NCT NCT06136949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06136949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Theranostic Value of STARD3 in Colorectal Cancer: The STAR Study: a Monocentric Observational Study
Lead sponsor
Centro di Riferimento Oncologico - Aviano
Phase
Observational
Overall status
Recruiting
Start date
May 22, 2023
Completion date
December 31, 2032
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer